Background
Methods
Inclusion and exclusion criteria
Definition of the outcomes
COPD
CB
Emphysema
Choice of outcome
Literature searching
Identification of studies
Data recorded
Identifying which RRs to enter
The major smoking indices
Dose-related smoking indices
Confounders adjusted for
Sex
Derivation of RRs
Data entry and checking
Selecting RRs for the meta-analyses
Carrying out the meta-analyses
Meta-regression analyses of the major smoking indices
Additional analyses
Software
Results
Studies identified
Reasona
| Number of publications | |
---|---|---|
IMMEDIATE REJECTS | 63 | |
Title of publication indicates it is irrelevant (abstract/paper unavailable) | 60 | |
Publication could not be obtained | 3 | |
PUBLICATION DOES NOT PROVIDE ORIGINAL DATA | 430 | |
Results the same as or superseded by another publication | 16 | |
Review (including guideline, handout, lecture, bibliography, meta-analysis) | 329 | |
Editorial | 31 | |
Comment, letter, interview or news article | 47 | |
Publication is a theoretical modelling exercise | 7 | |
STUDY POPULATION INAPPOPRIATE | 343 | |
Study of children or adolescents | 30 | |
Animal study | 5 | |
Study in population at high risk of respiratory disease, such as risky occupations | 71 | |
Study of alpha-1antitrypsin deficient subjects | 39 | |
Study of subjects with other coexisting diseases or conditions | 105 | |
Study of atypical populations | 7 | |
Subjects selected on smoking habits | 61 | |
Study of symptom-free or symptom-restricted populations | 25 | |
STUDY DESIGN INAPPROPRIATE | 323 | |
Not a case-control, prospective or cross-sectional study | 84 | |
Study of cases only | 216 | |
Control group not appropriate | 9 | |
Selection of subjects not clear | 14 | |
OUTCOME INAPPROPRIATE | 566 | |
Outcome not relevant | 557 | |
Study of undiagnosed disease | 4 | |
Study of disease exacerbation | 5 | |
USEFUL RESULTS BY SMOKING UNAVAILABLE | 425 | |
Never smokers not considered | 36 | |
No relevant results by smoking | 304 | |
Comparisons with never smokers and ex-smokers combined | 17 | |
Study of smokers of unusual cigarettes (e.g. chuttas) | 2 | |
Relative risks not calculable | 61 | |
Relative risks adjusted for symptoms or precursors of disease | 5 | |
Total rejected | 2150 |
Study REF [refs] | Study typea
| Country | Yearsb
| Populationc
| Outcome(s)d
| Study group (if Subsid)e
| Weaknessf
|
---|---|---|---|---|---|---|---|
CCh | UK/England | 1977-82 | CB | No | |||
ALESSA [28] | CCp | Italy | 1992-93 | COPD | Yes | ||
AMIGO [29] | CCh | Chile | 2001-03 | COPD | No | ||
ANDER1 [30] | CS | Canada | 1963 | COPD, CB | No | ||
ANDER2 [31] | CS | USA | (ca 1964?) | EM | No | ||
CCp | Poland | (ca 1997?) | COPD | Yes | |||
CS | USA | 1963-70 | EM | No | |||
BANG [36] | CS | USA | 1982-84 | hispanic | CB | No | |
BECK1 [37] | CS | USA | 1972-73 | CB | No | ||
BECK2 [37] | P | USA | 1972-73/1978 | CB | No | ||
BEDNAR [38] | CS | Poland | 2000-02 | COPD | No | ||
P | Canada | 1955-56/1962 | military veterans | COPD, CB, EM | No | ||
BJORNS [41] | CS | Sweden | 1990 | CB | No | ||
BROGGE [42] | CCm | Norway | 2003 | COPD | JOHANN | Yes | |
BROWN [43] | CS | UK/England | 1956 | CB | No | ||
CERVER [44] | CS | Italy | 1998-00 | CB | No | ||
CHAPMA [45] | CS | USA | 1976 | parents | CB | HOUSE | No |
CHEN1 [46] | P | China | 1972-78/1993 | workers at 11 factories | COPD | No | |
CHEN2 [47] | CS | Canada | 1994-95 | household members | COPD | No | |
CHEN3 [48] | CS | Canada | 2000-01 | household members | COPD | Yes | |
CHENG [49] | CS | China | 1992 | COPD | No | ||
CLEMEN [50] | P | Belgium | 1960-*/1975 | Air Force personnel | COPD | No | |
COATES [51] | CS | USA | 1962 | Post Office employees | CB | No | |
COCCI [52] | CCp | Italy | (ca 2000?) | COPD | Yes | ||
CS | UK/GB | (ca 1960?) | CB | No | |||
CCp | UK/England | 1969-73 | COPD | Yes | |||
DEAN2 [57] | CS | UK/GB | 1972 | CB | No | ||
DEANE [58] | CS | USA | 1963 | telephone company employees | CB | No | |
DEJONG [59] | CS | USA | (ca 2003?) | COPD | Yes | ||
CS | Multi-Europe | 1991-93 | COPD, CB | No | |||
DETORR [63] | CS | Spain | 2001-03 | patients | COPD | Yes | |
DICKIN [64] | CS | UK/England | (ca 1997?) | COPD | No | ||
P | UK | 1951/1991 | doctors | COPD, CB | No | ||
P | UK | 1951/1973 | doctors | COPD, CB | No | ||
DONTA1 [69] | CS | Greece | 1960 | COPD | JACOBS | Yes | |
DONTA2 [69] | P | Greece | 1960/1970 | CB, EM | JACOBS | Yes | |
DOPICO [70] | CS | USA | (ca 1982?) | employedg
| CB | No | |
EHRLIC [71] | CS | South Africa | 1998 | household members | CB | No | |
EKBERG [72] | CS | Sweden | 1974-92 | COPD | No | ||
ENRIGH [73] | CS | USA | 1989-90 | health insurance members | CB, EM | No | |
ENSTRO [74] | P | USA | 1960/1998 | household members | COPD | HAMMO2 | No |
CS | USA | 1961 | household members | COPD, CB | FERRI2 | No | |
CS | USA | 1967 | household members, long term residents | COPD | No | ||
FERRI3 [79] | CS | USA | 1973 | household members, long term residents | COPD | FERRI2 | No |
FIDAN [80] | CS | Turkey | 2000-01 | coffeehouse or shop workers | COPD | No | |
FINKLE [81] | CS | USA | 1969-70 | military recruits | CB | No | |
FLETCH [82] | CS | UK | 1956-57 | employedg
| CB | No | |
FORAST [83] | CS | USA | 1993-94 | COPD | Yes | ||
FOXMAN [84] | CS | USA | (ca 1981?) | CB | No | ||
FUKUCH [85] | CS | Japan | 2000 | household members | COPD | No | |
GEIJER [86] | P | Netherlands | 1998/2003 | COPD | No | ||
P | Denmark | 1964-93/1997 | COPD | No | |||
GOLDBE [88] | CS | USA | 1970 | parents | CB | No | |
CS | Norway | 1972-74 | COPD, EM | No | |||
HAENSZ [92] | CS | Norway | 1964 | mixedh
| CB | No | |
P | USA | 1959-60/1965 | household members | COPD, EM | No | ||
HARDIE [98] | CS | Norway | 1998-99 | COPD, CB, EM | No | ||
HARIKK [99] | P | USA | 1962-*/(ca 2000?) | COPD | No | ||
HARRIS [100] | CS | Nigeria | (ca 1992?) | soldiers | CB | No | |
HAWTHO [101] | P | UK/Scotland | 1965-75/1977 | mixedh
| COPD, CB | TANG | Yes |
HAYES [102] | CS | USA | 1970 | parents | CB | No | |
HEDMAN [103] | CS | Finland | 1996 | COPD | No | ||
HIGGI2 [104] | CS | UK/Wales | 1956 | CB | PETO | No | |
HIGGI3 [105] | CS | UK/Scotland | 1956 | CB | No | ||
P | USA | 1962-79/1987 | COPD | Yes | |||
CS | USA | 1962-65 | CB | HIGGI4 | No | ||
P | Japan | 1965/1982 | CB, EM | No | |||
CS | Hong Kong | 1991 | long term residents | COPD, CB, EM | No | ||
HOLLA2 [114] | CS | USA | 1962 | telephone company employees | CB | No | |
CS | Denmark | 1976-77 | CB | No | |||
HOUSE [117] | CS | USA | 1970 | parents | CB | No | |
CS | USA | 1987-89 | COPD, EM | No | |||
HRUBEC [121] | CS | USA | (ca 1972?) | veterans and twins | CB | No | |
HUCHON [122] | CS | France | (ca 2001?) | household members | CB | No | |
HUHTI1 [123] | CS | Finland | 1961 | COPD, CB, EM | No | ||
HUHTI2 [124] | CS | Finland | 1971 | long term residents | COPD, CB | HUHTI1 | No |
HUHTI3 [125] | CS | Finland | 1968-70 | COPD, CB | No | ||
ITABAS [126] | CCp | Japan | (ca 1989?) | COPD | Yes | ||
JACOBS [127] | P | Multi-Europe | 1957-64/(ca 1989?) | COPD | No | ||
JAENDI [128] | CS | Spain | 2001-02 | patients | COPD | Yes | |
JENSEN [129] | CS | Denmark | (ca 1996?) | patients | CB | Yes | |
JINDA2 [130] | CS | India | (ca 2004?) | household members | CB | No | |
CS | Norway | 1996-97 | long term residents | COPD | No | ||
JOSHI [135] | CS | India | (ca 1974?) | employedg
| CB | No | |
JOUSI1 [136] | CS | Finland | 1972-77 | CB | No | ||
KACHEL [137] | CS | Poland | (ca 2002?) | workers at five factories | COPD | No | |
P | USA | 1954-57/1980 | military veterans | COPD, CB, EM | No | ||
KAHN2 [138] | P | USA | 1954-57/1962 | military veterans | COPD, CB, EM | KAHN | No |
KARAKA [145] | NCCp | Greece | */1996 | COPD | VINEIS | No | |
KATANC [146] | CS | USA | 1997-98 | mixedh
| COPD | No | |
KATO [147] | CS | Japan | 1985 | CB | No | ||
KHOURY [148] | CS | USA | (1970s) | mixedh
| COPD | Yes | |
KIM [149] | CS | Korea | 2001-02 | household members | COPD | No | |
KIRAZ [150] | CS | Turkey | 1999 | mixedh
| COPD, CB | No | |
KLAYTO [151] | CS | USA | (ca 1974?) | employedg
| COPD | Yes | |
KOJIMA [152] | CS | Japan | 2001-02 | COPD | No | ||
KOTAN1 [153] | CS | Finland | 1995-96 | CB | No | ||
KOTAN2 [154] | CS | Finland | 1996-97 | COPD | KOTAN1 | No | |
KRZYZA [155] | P | Poland | 1968/1981 | COPD | No | ||
KUBIK [156] | CS | Czechoslovakia | 1972 | CB | Yes | ||
KULLER [157] | P | USA | 1972-74/1980 | volunteers | COPD | No | |
LAI [158] | CS | China | 2001-03 | COPD | No | ||
LAM1 [159] | P | China | 1976/1996 | employedg
| COPD | No | |
CS | China | 1987 | military veterans | COPD | No | ||
P | China | 1987/2005 | military veterans | COPD | No | ||
CS | UK | 1965 | household members | CB | TODD | No | |
P | Denmark | 1976-78/1989 | COPD | GODTFR | No | ||
LANGE2 [170] | CS | Denmark | 1991-94 | CB | VESTBO | No | |
LANGHA [19] | CS | Norway | 1995-97 | CB | No | ||
LAVECC [171] | CS | Italy | 1983 | household members | CB, EM | No | |
CS | USA | 1972-73 | household members | COPD, CB, EM | No | ||
P | UK | 1964-65/1977 | siblings of migrants | COPD | No | ||
LIAW [179] | P | Taiwan | 1982-86/1993 | volunteers | COPD | WEN | No |
LINDBE [180] | P | Sweden | 1996/2003 | long term residents | COPD | No | |
LINDST [181] | CS | Europe | (ca 1998?) | COPD, CB | No | ||
LIU1 [182] | CCd | China | 1986-91 | COPD | No | ||
CS | China | 2002-03 | COPD | No | |||
CS | Sweden | 1996-97 | long term residents | COPD | No | ||
CCp | Sweden | 1986 | CB | LUNDB1 | Yes | ||
MADOR [190] | CCh | USA | (ca 2002?) | military veterans | COPD | No | |
MAGNUS [191] | CS | Iceland | 1993 | CB | No | ||
MANFRE [192] | CS | Canada | 1978-79 | CB | No | ||
CS | USA | 1988-94 | COPD | No | |||
CS | USA | 1971-75 | household members | COPD | No | ||
MANNI3 [199] | P | USA | 1971-75/1992 | household members | COPD | No | |
MARAN1 [201] | CS | Thailand | 1998 | COPD | Yes | ||
MARAN2 [201] | P | Thailand | 1998/1999 | COPD | Yes | ||
MARCUS [202] | P | USA | 1965-68/1984 | Japanese ancestry | COPD | No | |
MATHES [203] | CCp | Australia | (ca 2005?) | COPD | No | ||
MELLST [204] | CS | Sweden | 1971-77 | CB | No | ||
MENEZ1 [205] | CS | Brazil | 1990 | household members | CB | No | |
CS | Brazil | 2003 | household members | COPD | No | ||
MENEZ3 [206] | CS | Chile | 2003 | household members | COPD | No | |
MENEZ4 [206] | CS | Mexico | 2003 | household members | COPD | No | |
MENEZ5 [206] | CS | Uruguay | 2003 | household members | COPD | No | |
MENEZ6 [206] | CS | Venezuela | 2003 | household members | COPD | No | |
MEREN [208] | CS | Estonia | 1995-96 | CB | No | ||
MILLER [209] | CS | USA | 1978 | household members | CB, EM | No | |
CS | UK/Scotland | 1968-70 | CB | No | |||
MOLLER [212] | CCp | Germany | (ca 1999?) | CB | Yes | ||
CS | Sweden | 1992 | COPD | No | |||
MUELLE [216] | CS | USA | 1967 | household members | COPD, CB | No | |
NAWA [217] | CS | Japan | 1998-00 | mixedh
| EM | No | |
NEJJAR [218] | CS | France | 1991 | household members | CB | No | |
NIEPSU [219] | CS | Poland | 2001 | COPD | Yes | ||
P | Sweden | 1992/2000 | long term residents | COPD | No | ||
P | Sweden | 1963/1996 | COPD | No | |||
OGILVI [225] | CCp | UK/England | 1955-56 | household members | CB | No | |
OMORI [226] | CS | Japan | (ca 2004?) | EM | Yes | ||
OSWAL1 [227] | CCh | UK/England | 1951-53 | mixedh
| CB | No | |
OSWAL2 [228] | CS | UK/England | 1954-55 | civil servants | CB | Yes | |
CS | Nepal | 1979-80 | CB | No | |||
P | Australia | 1966-75/1984 | COPD | No | |||
PELKON [233] | P | Finland | 1959/2000 | COPD, CB | JACOBS | No | |
PEREZP [234] | CCm | Mexico | 1992-94 | COPD, CB | No | ||
PETO [235] | P | UK/England and Wales | 1954-61/1981 | mixedh
| COPD | Yes | |
PRATT [236] | CS | USA | (ca 1978?) | military veterans | EM | Yes | |
CS | UK | (ca 2004?) | COPD | No | |||
REID [239] | CS | USA | 1962-63 | mixedh
| CB | No | |
RENWIC [240] | CS | UK/England | 1992-94 | COPD | No | ||
RICCIO [241] | CS | Italy | 2002 | patients | COPD | Yes | |
CS | UK/England | 1970 | volunteers | CB | No | ||
RYDER [244] | CS | UK/Wales | (ca 1969?) | EM | No | ||
CS | UK/England | 1993-96 | COPD | VINEIS | No | ||
CS | Poland | 1968 | COPD, CB | No | |||
CS | USA | 1976-80 | household members | CB | No | ||
SHAHAB [251] | CS | England | 2001 | COPD | No | ||
CS | USA | 1960-61 | employedg
| CB | No | ||
SHIMUR [254] | CCh | Japan | (ca 1994?) | CB | Yes | ||
SHIN [255] | CS | Korea | 1999-00 | household members | COPD | No | |
SICHLE [256] | CS | Greece | 2000-01 | COPD | No | ||
P | USA | 1972-*/(ca 1992?) | household members | COPD, CB, EM | No | ||
CS | Spain | 1996-97 | CB | No | |||
SPEIZE [265] | P | USA | 1974-77/1986 | household members | COPD | No | |
CCp | USA | 1986-87 | COPD | Yes | |||
STJERN [268] | CS | Sweden | 1981 | CB | No | ||
STROM [269] | CS | Sweden | 1982-83 | long term residents | COPD | No | |
SUADIC [270] | CS | Denmark | 1985-86 | employedg
| CB | No | |
SUTINE [271] | CS | Finland | 1971-72 | EM | No | ||
TAGER [272] | CS | USA | 1973-74 | COPD | No | ||
TAGER2 [273] | CS | USA | 1973-74 | household members | CB | Yes | |
TANG [274] | P | UK | 1967-82/* | mixedh
| COPD | No | |
P | USA | 1982/1988 | household members | COPD | No | ||
P | UK | 1965-66/1977 | household members | COPD | No | ||
TROISI [277] | P | USA | 1980/1990 | nurses | CB | No | |
CS | USA | 2001 | telephone subscribers | COPD | No | ||
TSUSHI [280] | CS | Japan | 2003-04 | volunteers | COPD | No | |
TVERDA [281] | P | Norway | 1972-78/1988 | COPD | Yes | ||
URRUTI [282] | CS | Spain | (ca 2004?) | CB | DEMARC | No | |
CS | Denmark | 1976-78 | COPD | No | |||
VIEGI1 [284] | CS | Italy | 1980-82 | household members | CB | No | |
VIEGI2 [285] | CS | Italy | 1988-91 | COPD | No | ||
P | Sweden | 1994-95/2001 | long term residents | EM | No | ||
VINEIS [289] | P | Europe | 1993-98/(ca 2003?) | volunteers | COPD | No | |
VOLLM1 [290] | CS | USA | 1971-72 | volunteers | COPD | VOLLM2 | Yes |
VOLLM2 [290] | P | USA | 1971-72/1982 | volunteers | COPD | Yes | |
VONHER [291] | CS | Finland | 1978-80 | COPD | No | ||
CCp | Netherlands | 2001 | employedg
| CB | No | ||
WALD [295] | P | UK/England | 1975-82/1993 | professional/business men | COPD | TANG | Yes |
WANG2 [296] | CS | Japan | 1996-98 | volunteers | EM | No | |
WATSON [297] | CCp | UK | (ca 2000?) | COPD | No | ||
WEISS [298] | CS | USA | 1961 | volunteers | COPD, EM | No | |
WEN [299] | P | Taiwan | 1982-92/2000 | mixedh
| COPD, CB, EM | No | |
WIG [300] | CS | India | (ca 1963?) | household members | CB | Yes | |
WILHEL [301] | CS | Sweden | 1967 | CB | No | ||
WILSO1 [302] | CS | Australia | 2000 | household members | COPD | No | |
WILSO2 [303] | CS | Australia | 1998 | household members | CB, EM | No | |
CS | Poland | 1968-73 | COPD, CB | SAWICK | No | ||
WOODS [306] | CS | Australia | (ca 1998?) | CB | No | ||
WOOLF [307] | CS | Canada | (ca 1970-73?) | employedg
| CB | No | |
XIAO [308] | CCp | China | (ca 2003?) | COPD | No | ||
XU [309] | CS | China | 2000-01 | long term residents | COPD | No | |
CS | China | 1986 | long term residents | COPD, CB | No | ||
YUAN [311] | P | China | 1986-89/1993 | COPD | No | ||
CS | Poland | 1999 | volunteers | COPD | No | ||
CS | Poland | 2000-03 | volunteers | COPD | No | ||
ZIETKO [318] | CCp | Poland | (ca 2003?) | COPD | Yes | ||
ZOIA [319] | CS | Italy | (ca 1993?) | CB | No |
Disease studied (principal studies) | Study type (principal studies)a
| Subsidiary | All | ||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | Level | COPD | CB | EMP | CC | Prosp | Cross-sec | studies | studies |
Study status | Principal | 116 | 87 | 26 | 20 | 39 | 134 | - | 193 |
Subsidiary | (17) | (14) | (2) | - | - | - | 25 | 25 | |
Study type | Case/control | 14 | 7 | 0 | 20 | - | - | 2 | 22 |
Prospective | 35 | 9 | 7 | - | 39 | - | 8 | 47 | |
Cross-sectional | 67 | 71 | 19 | - | - | 134 | 14 | 148 | |
Nested case/control | 0 | 0 | 0 | - | - | - | 1 | 1 | |
Study sex | Both | 89 | 62 | 18 | 17 | 20 | 108 | 20 | 165 |
Male | 23 | 20 | 8 | 2 | 17 | 23 | 5 | 47 | |
Female | 4 | 5 | 0 | 1 | 2 | 3 | 0 | 6 | |
Lowest ageb
| < 20 | 26 | 22 | 10 | 5 | 4 | 42 | 3 | 54 |
20-29 | 28 | 25 | 2 | 3 | 10 | 32 | 9 | 54 | |
30-39 | 23 | 12 | 4 | 6 | 15 | 11 | 6 | 38 | |
40-49 | 26 | 17 | 4 | 5 | 7 | 29 | 5 | 46 | |
50+ | 13 | 11 | 6 | 1 | 3 | 20 | 2 | 26 | |
Highest ageb
| < 50 | 3 | 6 | 0 | 0 | 2 | 6 | 1 | 9 |
50-59 | 4 | 8 | 0 | 0 | 4 | 8 | 1 | 13 | |
60-69 | 20 | 21 | 6 | 2 | 9 | 29 | 5 | 45 | |
70-79 | 19 | 12 | 1 | 4 | 6 | 19 | 8 | 37 | |
80+ | 70 | 39 | 19 | 14 | 18 | 71 | 10 | 113 | |
Unknown | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | |
Region | USA/Canada | 31 | 28 | 12 | 2 | 14 | 40 | 7 | 63 |
S/C America | 7 | 2 | 0 | 2 | 0 | 6 | 0 | 8 | |
UK | 11 | 13 | 1 | 5 | 6 | 12 | 5 | 28 | |
Western Europe | 8 | 9 | 1 | 4 | 2 | 11 | 1 | 18 | |
Scandinavia | 18 | 16 | 5 | 0 | 6 | 26 | 7 | 39 | |
Other Europe | 12 | 4 | 0 | 2 | 1 | 11 | 4 | 18 | |
Asia | 22 | 10 | 6 | 4 | 7 | 21 | 1 | 33 | |
Other | 3 | 4 | 1 | 1 | 1 | 5 | 0 | 7 | |
Multicountry | 4 | 1 | 0 | 0 | 2 | 2 | 0 | 4 | |
Start year of study | < 1960 | 7 | 10 | 3 | 2 | 7 | 4 | 3 | 16 |
1960-1969 | 19 | 15 | 4 | 1 | 12 | 17 | 8 | 38 | |
1970-79 | 15 | 19 | 5 | 1 | 9 | 23 | 6 | 39 | |
1980-89 | 12 | 10 | 4 | 2 | 5 | 13 | 2 | 22 | |
1990-99 | 23 | 16 | 6 | 2 | 6 | 29 | 3 | 40 | |
> 1999 | 25 | 1 | 0 | 2 | 0 | 24 | 1 | 27 | |
Unknown | 15 | 16 | 4 | 10 | 0 | 24 | 2 | 36 | |
Major study weakness | Present | 19 | 5 | 2 | 9 | 4 | 13 | 6 | 32 |
Smoking results available | Current v never | 89 | 70 | 15 | 14 | 34 | 98 | 23 | 169 |
Ex v never | 82 | 65 | 12 | 12 | 29 | 93 | 19 | 153 | |
Ever v never | 95 | 71 | 20 | 16 | 29 | 113 | 18 | 176 | |
Amount smoked | 39 | 42 | 10 | 7 | 23 | 47 | 14 | 91 | |
Age started | 13 | 3 | 1 | 5 | 7 | 5 | 3 | 20 | |
Pack years | 42 | 13 | 3 | 10 | 5 | 43 | 5 | 63 | |
Duration of smoking | 6 | 4 | 3 | 2 | 4 | 6 | 2 | 14 | |
Duration of quitting | 8 | 7 | 2 | 3 | 8 | 7 | 4 | 22 | |
Outcomes | COPD only | 93 | - | - | 13 | 28 | 52 | 11 | 104 |
CB only | - | 63 | - | 6 | 2 | 55 | 7 | 70 | |
Emp only | - | - | 9 | 0 | 1 | 8 | 0 | 9 | |
More than one | 23 | 24 | 17 | 1 | 8 | 19 | 7 | 35 | |
COPD | 116 | - | - | 14 | 35 | 67 | 17 | 133 | |
CB | - | 87 | - | 7 | 9 | 71 | 14 | 101 | |
Emp | - | - | 26 | 0 | 7 | 19 | 2 | 28 | |
All studies | 116 | 87 | 26 | 20 | 39 | 134 | 25 | 218 |
Relative risks
RRs | Characteristic | Level | Outcome | |||
---|---|---|---|---|---|---|
COPD | CB | Emphysema | Total | |||
All RRs | Total | Total | 1,342 | 1,311 | 210 | 2,863 |
Study type | Case/control | 194 | 162 | 0 | 356 | |
Prospective | 414 | 86 | 66 | 566 | ||
Cross-sectional | 734 | 1,063 | 144 | 1,941 | ||
Sex | Both | 289 | 215 | 35 | 539 | |
Male | 660 | 552 | 114 | 1,326 | ||
Female | 393 | 544 | 61 | 998 | ||
Adjusted for any variable | No | 605 | 677 | 93 | 1,375 | |
Yes | 737 | 634 | 117 | 1,488 | ||
Adjusted for age | No | 624 | 758 | 99 | 1,481 | |
Yes | 718 | 553 | 111 | 1,382 | ||
Adjusted for other confoundersb
| No | 1,051 | 1,135 | 187 | 2,373 | |
Yes | 291 | 176 | 23 | 490 | ||
Derivation | Original or 2 × 2c
| 409 | 478 | 86 | 973 | |
Other derived | 933 | 833 | 124 | 1890 | ||
RRs for major smoking indices | Total | Total | 551 | 547 | 105 | 1,203 |
Exposed group: smoking status | Ever | 185 | 186 | 45 | 416 | |
Current | 214 | 205 | 36 | 455 | ||
Ex | 152 | 156 | 24 | 332 | ||
Exposed group: smoking product | Any product | 166 | 211 | 29 | 406 | |
Cigarettes (+/- other) | 314 | 269 | 62 | 645 | ||
Cigarettes only | 71 | 67 | 14 | 152 | ||
Unexposed | Never any product | 283 | 335 | 53 | 671 | |
Never cigarettes | 261 | 206 | 52 | 519 | ||
Otherd
| 7 | 6 | 0 | 13 | ||
RRs for all dose-response indices | Total | Total | 791 | 764 | 105 | 1,660 |
Exposed group: smoking status | Ever | 221 | 138 | 19 | 378 | |
Current | 415 | 492 | 83 | 990 | ||
Ex | 155 | 134 | 3 | 292 | ||
Exposed group: smoking product | Any product | 64 | 176 | 8 | 248 | |
Cigarettes (+/- other) | 525 | 399 | 69 | 993 | ||
Cigarettes only | 202 | 189 | 28 | 419 | ||
Unexposed | Never (any or cigs) | 389 | 387 | 60 | 836 | |
Lowe (any or cigs) | 318 | 295 | 38 | 651 | ||
Current (any or cigs) | 33 | 32 | 0 | 65 | ||
Otherf/not applicableg
| 51 | 50 | 7 | 108 | ||
RRs for amount smoked | Total | Total | 335 | 474 | 65 | 874 |
Exposed group: smoking status | Ever | 3 | 51 | 9 | 63 | |
Current | 323 | 413 | 55 | 791 | ||
Ex | 9 | 10 | 1 | 20 | ||
Sets for amount smoked | vs. never (any or cigs) | 66 | 94 | 14 | 174 | |
vs. low amount | 65 | 97 | 16 | 178 | ||
vs. nonh
| 2 | 9 | 0 | 11 | ||
Non categorical | 9 | 11 | 3 | 23 | ||
RRs for age started | Total | Total | 78 | 50 | 6 | 134 |
Exposed group: smoking status | Ever | 6 | 38 | 0 | 44 | |
Current | 65 | 12 | 6 | 83 | ||
Ex | 7 | 0 | 0 | 7 | ||
Sets for age started | vs. never (any or cigs) | 12 | 4 | 2 | 18 | |
vs. later start | 21 | 9 | 2 | 32 | ||
vs. nonh
| 1 | 0 | 0 | 1 | ||
Non categorical | 6 | 0 | 0 | 6 | ||
RRs for pack-years | Total | Total | 225 | 88 | 15 | 328 |
Exposed group: smoking status | Ever | 208 | 48 | 5 | 261 | |
Current | 14 | 30 | 10 | 54 | ||
Ex | 3 | 10 | 0 | 13 | ||
Sets for pack-years | vs. never (any or cigs) | 34 | 15 | 3 | 52 | |
vs. low pack-years | 41 | 15 | 3 | 59 | ||
Non categorical | 25 | 9 | 2 | 36 | ||
RRs for duration of smoking | Total | Total | 17 | 39 | 17 | 73 |
Exposed group: smoking status | Ever | 4 | 1 | 5 | 10 | |
Current | 13 | 37 | 12 | 62 | ||
Ex | 0 | 1 | 0 | 1 | ||
Sets for duration of smoking | vs. never (any or cigs) | 2 | 6 | 3 | 11 | |
vs. low duration | 2 | 6 | 2 | 10 | ||
Non categorical | 5 | 5 | 0 | 10 | ||
RRs for duration of quitting | Total | Total | 136 | 113 | 2 | 251 |
Sets for duration of quitting | vs. never (any or cigs) | 13 | 13 | 0 | 26 | |
vs. current | 12 | 11 | 0 | 23 | ||
vs. long term ex | 14 | 11 | 0 | 25 | ||
vs. recent ex | 14 | 11 | 0 | 25 | ||
Non categorical | 2 | 3 | 2 | 7 |
The meta-analyses and meta-regressions
A. Risk from ever smoking
Characteristic | Level | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|---|
All | All | n | 129 | 114 | 28 |
F | 2.34 (2.27-2.40) | 2.42 (2.36-2.48) | 3.22 (2.95-3.52) | ||
R | 2.89 (2.63-3.17) | 2.69 (2.50-2.90) | 4.51 (3.38-6.02) | ||
H, PH
| 8.11, < 0.001 | 5.81, < 0.001 | 6.42, < 0.001 | ||
Sex | Male | n | 49 | 51 | 13 |
F | 2.69 (2.55-2.84) | 2.87 (2.74-3.00) | 5.71 (4.74-6.87) | ||
R | 3.60 (2.98-4.34) | 3.18 (2.77-3.65) | 5.42 (3.69-7.96) | ||
Female | n | 35 | 39 | 6 | |
F | 2.16 (2.04-2.28) | 2.22 (2.11-2.32) | 3.44 (2.60-4.55) | ||
R | 2.73 (2.17-3.43) | 2.57 (2.28-2.89) | 3.25 (2.07-5.10) | ||
Combined | n | 45 | 24 | 9 | |
F | 2.26 (2.17-2.35) | 2.24 (2.15-2.33) | 2.62 (2.36-2.92) | ||
R | 2.51 (2.23-2.82) | 2.29 (2.05-2.57) | 4.47 (2.72-7.34) | ||
Between levels | PB
| NS | < 0.001 | < 0.05 | |
Continent | N America | n | 35 | 38 | 14 |
F | 3.21 (3.04-3.39) | 2.91 (2.75-3.07) | 5.33 (4.49-6.33) | ||
R | 3.48 (2.88-4.20) | 3.17 (2.70-3.71) | 5.32 (3.86-7.32) | ||
Europe | n | 59 | 60 | 10 | |
F | 2.09 (2.01-2.17) | 2.34 (2.27-2.41) | 2.19 (1.95-2.46) | ||
R | 2.79 (2.46-3.16) | 2.62 (2.39-2.89) | 3.13 (2.01-4.87) | ||
Asia | n | 23 | 9 | 4 | |
F | 2.26 (2.08-2.45) | 2.08 (1.92-2.24) | 5.76 (4.59-7.23) | ||
R | 2.73 (2.15-3.46) | 2.21 (1.78-2.75) | 5.59 (3.93-7.95) | ||
Other or multicountry | n | 12 | 7 | 0 | |
F | 1.91 (1.71-2.14) | 2.34 (2.09-2.61) | |||
R | 2.13 (1.66-2.73) | 2.09 (1.59-2.74) | |||
Between levels | PB
| < 0.001 | < 0.05 | < 0.001 | |
Publication year | Before 1980 | n | 25 | 49 | 13 |
F | 3.82 (3.40-4.29) | 3.02 (2.86-3.18) | 5.81 (4.74-7.12) | ||
R | 3.79 (2.82-5.10) | 3.22 (2.82-3.68) | 5.37 (3.72-7.75) | ||
1980-89 | n | 10 | 28 | 5 | |
F | 2.13 (1.80-2.50) | 2.44 (2.33-2.56) | 2.10 (1.86-2.37) | ||
R | 2.34 (1.79-3.05) | 2.72 (2.33-3.17) | 2.39 (1.49-3.82) | ||
1990-99 | n | 19 | 17 | 3 | |
F | 3.75 (3.36-4.18) | 2.09 (1.96-2.22) | 3.14 (2.34-4.22) | ||
R | 3.31 (2.39-4.58) | 2.24 (1.91-2.63) | 3.14 (2.34-4.22) | ||
2000 or later | n | 75 | 20 | 7 | |
F | 2.19 (2.13-2.26) | 2.19 (2.09-2.29) | 5.76 (4.72-7.04) | ||
R | 2.62 (2.36-2.90) | 2.19 (1.93-2.48) | 5.58 (3.63-5.58) | ||
Between levels | PB
| < 0.001 | < 0.001 | < 0.001 | |
Study type | Case-control | n | 16 | 10 | 0 |
F | 2.51 (2.10-2.99) | 2.35 (2.04-2.69) | |||
R | 2.95 (2.14-4.06) | 2.72 (1.85-3.77) | |||
Prospective | n | 37 | 11 | 6 | |
F | 4.49 (4.12-4.89) | 2.30 (2.08-2.55) | 6.12 (4.77-7.85) | ||
R | 3.71 (2.94-4.69) | 2.60 (2.04-3.30) | 4.95 (2.72-8.99) | ||
Cross-sectional | n | 76 | 93 | 22 | |
F | 2.16 (2.10-2.22) | 2.43 (2.36-2.49) | 2.93 (2.67-3.22) | ||
R | 2.54 (2.32-2.80) | 2.70 (2.49-2.93) | 4.36 (3.19-5.96) | ||
Between levels | PB
| < 0.001 | NS | < 0.05 | |
Outcome subtype | Mortality | n | 29 | 3 | 4 |
F | 4.50 (4.09-4.94) | 4.10 (2.54-6.60) | 8.24 (6.24-10.87) | ||
R | 3.95 (3.00-5.21) | 5.49 (2.14-14.11) | 8.24 (6.24-10.87) | ||
Lung function (COPD) or symptoms (CB) | n | 60 | 83 | 0 | |
F | 2.16 (2.09-2.23) | 2.51 (2.44-2.58) | |||
R | 2.35 (2.13-2.59) | 2.78 (2.55-3.03) | |||
Other | n | 40 | 28 | 24 | |
F | 2.31 (2.19-2.45) | 2.11 (2.00-2.22) | 2.89 (2.63-3.18) | ||
R | 3.10 (2.56-3.76) | 2.31 (2.01-2.65) | 4.00 (2.97-5.37) | ||
Between levels | PB
| < 0.001 | < 0.05 | < 0.01 | |
How asthma taken into account | Ignored | n | 76 | 103 | 26 |
F | 2.60 (2.52-2.70) | 2.44 (2.38-2.50) | 3.22 (2.94-3.52) | ||
R | 2.95 (2.62-3.32) | 2.69 (2.50-2.91) | 4.61 (3.43-6.19) | ||
Excluded | n | 21 | 7 | 2 | |
F | 1.83 (1.73-1.94) | 1.91 (1.71-2.13) | 3.22 (1.45-7.11) | ||
R | 2.35 (1.92-2.87) | 2.13 (1.61-2.80) | 3.20 (0.36-28.37) | ||
Included in outcome definition | n | 19 | - | - | |
F | 1.76 (1.61-1.92) | ||||
R | 2.55 (2.00-3.26) | ||||
Other | n | 13 | 4 | 0 | |
F | 3.68 (3.20-4.24) | 5.41 (3.58-8.18) | |||
R | 3.62 (2.80-4.69) | 5.37 (3.13-9.21) | |||
Between levels | PB
| < 0.001 | < 0.1 | NS | |
Number of cases | 1-50 | n | 23 | 17 | 6 |
F | 4.06 (3.12-5.29) | 2.70 (1.98-3.69) | 2.89 (1.78-4.67) | ||
R | 4.45 (3.19-6.21) | 2.70 (1.98-3.69) | 2.89 (1.78-4.67) | ||
51-100 | n | 29 | 13 | 9 | |
F | 2.42 (2.12-2.75) | 3.71 (2.91-4.72) | 2.87 (2.15-3.83) | ||
R | 2.55 (2.09-3.12) | 4.15 (2.97-5.80) | 3.19 (2.10-4.85) | ||
101-200 | n | 30 | 19 | 5 | |
F | 2.39 (2.18-2.63) | 3.07 (2.66-3.53) | 7.30 (5.31-10.03) | ||
R | 2.69 (2.24-3.24) | 3.48 (2.64-4.58) | 7.48 (4.73-11.85) | ||
201+ | n | 47 | 65 | 8 | |
F | 2.31 (2.24-2.38) | 2.38 (2.32-2.44) | 3.03 (2.74-3.24) | ||
R | 2.91 (2.54-3.32) | 2.51 (2.31-2.72) | 4.96 (2.99-8.22) | ||
Between levels | PB
| NS | NS | NS | |
Analysis type | Prevalence | n | 93 | 105 | 22 |
F | 2.17 (2.11-2.23) | 2.43 (2.37-2.50) | 2.93 (2.67-3.22) | ||
R | 2.57 (2.35-2.81) | 2.71 (2.51-2.93) | 4.36 (3.19-5.96) | ||
Onset | n | 36 | 9 | 6 | |
F | 4.55 (4.17-4.96) | 2.02 (1.78-2.28) | 6.12 (4.77-7.85) | ||
R | 3.77 (2.98-4.78) | 2.37 (1.80-3.13) | 4.95 (2.72-8.99) | ||
Between levels | PB
| < 0.001 | NS | < 0.05 | |
Smoking product | Any | n | 48 | 61 | 11 |
F | 2.60 (2.47-2.74) | 2.59 (2.51-2.68) | 2.51 (2.24-2.80) | ||
R | 2.99 (2.61-3.44) | 2.89 (2.63-3.19) | 4.16 (2.55-6.78) | ||
Cigarettes (ignoring other products) | n | 73 | 51 | 15 | |
F | 2.08 (2.01-2.15) | 2.18 (2.10-2.26) | 4.96 (4.26-5.78) | ||
R | 2.48 (2.23-2.76) | 2.44 (2.17-2.73) | 4.58 (3.33-6.30) | ||
Cigarettes only | n | 8 | 2 | 2 | |
F | 6.38 (5.61-7.24) | 3.03 (2.29-4.01) | 6.69 (3.43-13.05) | ||
R | 6.42 (4.22-9.78) | 5.04 (1.29-19.70) | 6.69 (3.43-13.05) | ||
Between levels | PB
| < 0.001 | < 0.05 | < 0.01 | |
Unexposed basec
| Never any product | n | 57 | 70 | 14 |
F | 2.95 (2.82-3.09) | 2.61 (2.52-2.69) | 2.75 (2.47-3.06) | ||
R | 3.44 (2.95-4.01) | 2.90 (2.65-3.18) | 4.76 (3.02-7.50) | ||
Never cigarettes | n | 72 | 44 | 14 | |
F | 2.05 (1.98-2.12) | 2.16 (2.07-2.24) | 4.62 (3.93-5.43) | ||
R | 2.47 (2.22-2.74) | 2.42 (2.15-2.73) | 4.28 (3.08-5.96) | ||
Between levels | PB
| < 0.001 | < 0.01 | < 0.05 | |
RR adjusted for age | Yes | n | 69 | 63 | 15 |
F | 2.46 (2.35-2.56) | 2.17 (2.10-2.24) | 2.70 (2.43-3.00) | ||
R | 2.97 (2.56-3.45) | 2.46 (2.26-2.69) | 4.44 (2.90-6.82) | ||
No | n | 60 | 51 | 13 | |
F | 2.26 (2.18-2.34) | 2.78 (2.67-2.88) | 4.91 (4.17-5.79) | ||
R | 2.77 (2.46-3.12) | 3.03 (2.69-3.41) | 4.67 (3.45-6.33) | ||
Between levels | PB
| NS | < 0.001 | < 0.05 | |
RR adjusted for factors other than age or sex | Yes | n | 34 | 30 | 6 |
F | 2.09 (1.98-2.21) | 2.28 (2.20-2.37) | 2.11 (1.87-2.38) | ||
R | 2.64 (2.23-3.13) | 2.41 (2.14-2.71) | 2.11 (1.87-2.38) | ||
No | n | 95 | 84 | 22 | |
F | 2.43 (2.35-2.51) | 2.53 (2.45-2.61) | 5.26 (4.62-6.00) | ||
R | 3.00 (2.68-3.36) | 2.86 (2.60-3.15) | 5.02 (3.88-6.50) | ||
Between levels | PB
| < 0.1 | < 0.1 | < 0.001 |
Sex
Continent
Publication year
Study type
Outcome subtype
How asthma was taken into account
Study size
Analysis type
Smoking product
Unexposed base group
Age-adjustment
Adjustment for factors other than age or sex
COPD | CB | ||||
---|---|---|---|---|---|
Characteristic | Level | Estimateb (SEc) | pd
| Estimateb (SEc) | pd
|
Constant | +1.149 (0.141) | +1.316 (0.266) | |||
Sex | Male | Base | < 0.05 | Base | < 0.1 |
Female | -0.212 (0.044) | -0.171 (0.036) | |||
Combined | -0.006 (0.039) | -0.121 (0.077) | |||
Continent | N America | Base | < 0.05 | Base | < 0.01 |
Europe | -0.200 (0.040) | -0.278 (0.039) | |||
Asia | -0.295 (0.067) | -0.281 (0.060) | |||
Other | -0.355 (0.072) | -0.177 (0.074) | |||
Outcome subtype | Mortality | Base | < 0.01 | Base | NS |
Lung function (COPD) or symptoms (CB) | -0.404 (0.092) | -0.212 (0.249) | |||
Other | -0.114 (0.085) | -0.302 (0.248) | |||
How asthma taken into account | Ignored | Base | < 0.001 | Base | < 0.05 |
Excluded | -0.143 (0.043) | -0.109 (0.066) | |||
Included in outcome definition | -0.461 (0.060) | No data | |||
Other | +0.283 (0.093) | +0.996 (0.214) | |||
Smoking product | Any | Base | < 0.01 | Base | NS |
Cigarettes (ignoring other products) | +0.428 (0.128) | -0.060 (0.128) | |||
Cigarettes only | +0.589 (0.107) | +0.449 (0.149) | |||
Unexposed group | Never any product | Base | < 0.05 | Base | NS |
Never cigarettes | -0.603 (0.123) | -0.111 (0.126) | |||
RR adjusted for age | Yes | Base | NS | Base | < 0.01 |
No | +0.046 (0.045) | +0.214 (0.032) | |||
RR adjusted for factor other than age or sex | Yes | Base | < 0.1 | Base | NS |
No | +0.195 (0.052) | -0.113 (0.070) | |||
Midpoint age | Per 10 years | +0.003 (0.002) | NS | +0.003 (0.001) | NS |
B. Risk from current smoking
Characteristic | Level | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|---|
All | All | N | 120 | 113 | 22 |
F | 3.00 (2.91-3.09) | 2.82 (2.74-2.90) | 2.61 (2.33-2.93) | ||
R | 3.51 (3.08-3.99) | 3.41 (3.13-3.72) | 4.87 (2.83-8.41) | ||
H, PH
| 13.81, < 0.001 | 5.80, < 0.001 | 11.54, < 0.001 | ||
Sex | Male | N | 48 | 51 | 13 |
F | 3.80 (3.60-4.02) | 3.08 (2.90-3.28) | 6.71 (5.29-8.53) | ||
R | 4.11 (3.28-5.15) | 4.07 (3.44-4.83) | 7.66 (3.00-19.61) | ||
Female | n | 31 | 37 | 5 | |
F | 2.53 (2.39-2.68) | 2.75 (2.60-2.90) | 2.85 (1.94-4.18) | ||
R | 3.28 (2.35-4.58) | 3.23 (2.80-3.72) | 2.85 (1.94-4.18) | ||
Combined | n | 41 | 25 | 4 | |
F | 2.81 (2.69-2.95) | 2.74 (2.62-2.86) | 1.86 (1.62-2.14) | ||
R | 3.04 (2.60-3.55) | 2.98 (2.57-3.47) | 2.54 (1.54-4.20) | ||
Between levels | PB
| < 0.05 | NS | < 0.05 | |
Continent | N America | n | 39 | 40 | 10 |
F | 5.02 (4.76-5.29) | 3.44 (3.20-3.69) | 8.13 (6.32-10.45) | ||
R | 4.56 (3.69-5.62) | 4.11 (3.41-4.97) | 8.99 (3.34-24.26) | ||
Europe | n | 55 | 58 | 7 | |
F | 2.31 (2.22-2.41) | 2.79 (2.69-2.89) | 1.83 (1.58-2.11) | ||
R | 3.31 (2.80-3.92) | 3.28 (2.96-3.62) | 2.88 (1.36-6.09) | ||
Asia | n | 17 | 9 | 5 | |
F | 2.73 (2.45-3.05) | 1.83 (1.65-2.02) | 2.52 (1.83-3.47) | ||
R | 2.86 (2.27-3.60) | 2.26 (1.67-3.05) | 2.74 (1.50-4.99) | ||
Other or multicountry | n | 9 | 6 | 0 | |
F | 2.15 (1.89-2.44) | 3.32 (2.94-3.75) | |||
R | 2.37 (1.75-3.21) | 3.11 (2.33-4.16) | |||
Between levels | PB
| < 0.001 | < 0.001 | < 0.01 | |
Publication year | Before 1980 | n | 24 | 50 | 7 |
F | 5.64 (5.12-6.21) | 3.59 (3.36-3.84) | 15.01 (10.59-21.28) | ||
R | 3.81 (2.64-5.50) | 3.96 (3.41-4.59) | 10.21 (2.09-49.96) | ||
1980-89 | n | 11 | 26 | 6 | |
F | 2.18 (1.84-2.59) | 2.29 (2.16-2.44) | 1.83 (1.59-2.10) | ||
R | 2.47 (1.87-3.27) | 3.25 (2.67-3.96) | 1.83 (1.59-2.10) | ||
1990-99 | n | 18 | 17 | 3 | |
F | 6.20 (5.59-6.88) | 2.74 (2.56-2.93) | 3.65 (2.50-5.31) | ||
R | 4.91 (3.37-7.16) | 3.04 (2.51-3.68) | 3.57 (2.30-5.55) | ||
2000 or later | n | 67 | 20 | 6 | |
F | 2.60 (2.52-2.69) | 2.86 (2.72-3.01) | 4.04 (2.65-6.16) | ||
R | 3.13 (2.73-3.60) | 2.94 (2.50-3.47) | 4.57 (2.05-10.20) | ||
Between levels | PB
| < 0.001 | < 0.001 | < 0.01 | |
Study type | Case-control | n | 14 | 9 | 0 |
F | 3.72 (3.09-4.48) | 3.39 (2.90-3.96) | |||
R | 4.69 (2.83-7.77) | 3.66 (2.77-4.83) | |||
Prospective | n | 38 | 12 | 8 | |
F | 6.46 (6.01-6.95) | 2.96 (2.67-3.29) | 3.61 (2.81-4.64) | ||
R | 4.34 (3.38-5.56) | 3.12 (2.56-3.78) | 3.12 (1.74-5.60) | ||
Cross-sectional | n | 68 | 92 | 14 | |
F | 2.53 (2.45-2.62) | 2.78 (2.70-2.87) | 2.39 (2.10-2.73) | ||
R | 3.00 (2.63-3.41) | 3.42 (3.10-3.77) | 6.60 (2.74-15.92) | ||
Between levels | PB
| < 0.001 | NS | NS | |
Outcome subtype | Mortality | n | 31 | 4 | 5 |
F | 6.57 (6.09-7.10) | 4.16 (2.67-6.48) | 3.79 (2.87-5.00) | ||
R | 4.57 (3.39-6.15) | 4.96 (2.43-10.12) | 3.42 (1.60-7.35) | ||
Lung function (COPD) or symptoms (CB) | n | 56 | 81 | 0 | |
F | 2.41 (2.32-2.50) | 3.06 (2.95-3.17) | |||
R | 2.79 (2.42-3.20) | 3.63 (3.29-3.99) | |||
Other | n | 33 | 28 | 17 | |
F | 3.45 (3.21-3.70) | 2.24 (2.12-2.37) | 2.42 (2.13-2.74) | ||
R | 3.77 (3.01-4.72) | 2.69 (2.26-3.21) | 5.56 (2.65-11.68) | ||
Between levels | PB
| < 0.001 | < 0.001 | NS | |
How asthma taken into account | Ignored | n | 72 | 103 | 19 |
F | 3.78 (3.64-3.92) | 2.80 (2.72-2.89) | 2.59 (2.30-2.91) | ||
R | 3.60 (3.08-4.20) | 3.38 (3.08-3.70) | 5.02 (2.80-9.00) | ||
Excluded | n | 17 | 6 | 3 | |
F | 1.79 (1.69-1.90) | 2.85 (2.53-3.21) | 4.03 (1.85-8.77) | ||
R | 3.05 (2.34-3.97) | 3.30 (2.39-4.54) | 3.90 (0.57-26.55) | ||
Included in outcome definition | n | 18 | - | - | |
F | 2.11 (1.88-2.37) | ||||
R | 2.73 (2.10-3.55) | ||||
Other | n | 13 | 4 | 0 | |
F | 4.00 (3.42-4.67) | 6.93 (4.39-10.92) | |||
R | 4.03 (2.96-5.48) | 5.70 (2.63-12.37) | |||
Between levels | PB
| < 0.001 | NS | NS | |
Number of cases | 1-50 | n | 21 | 18 | 8 |
F | 4.62 (3.42-6.24) | 3.85 (2.81-5.28) | 2.09 (1.31-3.34) | ||
R | 4.90 (3.34-7.18) | 3.85 (2.81-5.28) | 2.09 (1.31-3.34) | ||
51-100 | n | 23 | 14 | 6 | |
F | 3.08 (2.64-3.60) | 4.92 (3.84-6.30) | 4.83 (3.06-7.61) | ||
R | 3.21 (2.48-4.16) | 5.28 (3.88-7.03) | 5.14 (2.53-10.45) | ||
101-200 | n | 29 | 19 | 1 | |
F | 2.61 (2.35-2.89) | 3.93 (3.41-4.52) | 14.50 (4.63-45.41) | ||
R | 2.92 (2.39-3.57) | 4.71 (3.37-6.57) | 14.50 (4.63-45.41) | ||
201+ | n | 47 | 62 | 7 | |
F | 3.02 (2.92-3.12) | 2.74 (2.66-2.83) | 2.48 (2.19-2.81) | ||
R | 3.66 (3.02-4.43) | 3.06 (2.78-3.27) | 6.62 (2.44-18.00) | ||
Between levels | PB
| NS | < 0.05 | NS | |
Analysis type | Prevalence | n | 84 | 103 | 14 |
F | 2.57 (2.48-2.65) | 2.82 (2.74-2.91) | 2.39 (2.10-2.73) | ||
R | 3.14 (2.78-3.56) | 3.44 (3.14-3.77) | 6.60 (2.74-15.92) | ||
Onset | n | 36 | 10 | 8 | |
F | 6.58 (6.11-7.09) | 2.75 (2.42-3.13) | 3.61 (2.81-4.64) | ||
R | 4.40 (3.41-5.69) | 3.00 (2.31-3.89) | 3.12 (1.74-5.60) | ||
Between levels | PB
| < 0.001 | NS | NS | |
Smoking product | Any | n | 46 | 57 | 5 |
F | 3.09 (2.92-3.26) | 2.84 (2.72-2.96) | 2.05 (1.78-2.36) | ||
R | 3.67 (3.05-4.40) | 3.54 (3.17-3.97) | 3.84 (1.20-12.22) | ||
Cigarettes (ignoring other products) | n | 66 | 52 | 16 | |
F | 2.67 (2.57-2.77) | 2.79 (2.67-2.91) | 4.37 (3.54-5.40) | ||
R | 3.06 (2.60-3.60) | 3.27 (2.84-3.76) | 5.11 (2.45-10.65) | ||
Cigarettes only | n | 8 | 4 | 1 | |
F | 8.51 (7.55-9.59) | 3.27 (2.55-4.20) | 7.72 (2.39-24.94) | ||
R | 7.47 (4.63-12.05) | 3.36 (2.24-5.05) | 7.72 (2.39-24.94) | ||
Between levels | PB
| < 0.001 | NS | NS | |
Unexposed basec
| Never any product | n | 58 | 69 | 7 |
F | 4.07 (3.89-4.26) | 2.89 (2.77-3.01) | 2.41 (2.11-2.77) | ||
R | 4.27 (3.51-5.19) | 3.56 (3.20-3.96) | 8.93 (1.83-43.50) | ||
Never cigarettes | n | 62 | 44 | 15 | |
F | 2.34 (2.25-2.44) | 2.74 (2.63-2.87) | 3.18 (2.56-3.96) | ||
R | 2.87 (2.48-3.31) | 3.21 (2.77-3.72) | 3.30 (2.39-4.56) | ||
Between levels | PB
| < 0.001 | NS | NS | |
RR adjusted for age | Yes | n | 63 | 65 | 13 |
F | 3.47 (3.30-3.65) | 2.57 (2.48-2.67) | 2.52 (2.23-2.85) | ||
R | 3.66 (3.07-4.36) | 3.05 (2.74-3.39) | 5.77 (2.77-12.02) | ||
No | n | 57 | 48 | 9 | |
F | 2.76 (2.66-2.87) | 3.33 (3.17-3.51) | 3.57 (2.49-5.14) | ||
R | 3.34 (2.76-4.04) | 4.10 (3.57-4.71) | 3.35 (1.90-5.91) | ||
Between levels | PB
| < 0.1 | < 0.001 | NS | |
RR adjusted for factors other than age or sex | Yes | n | 27 | 29 | 6 |
F | 2.77 (2.61-2.94) | 2.77 (2.65-2.88) | 1.87 (1.62-2.15) | ||
R | 3.17 (2.65-3.80) | 2.97 (2.57-3.44) | 2.62 (1.65-4.17) | ||
No | n | 93 | 84 | 16 | |
F | 3.09 (2.98-3.20) | 2.87 (2.75-3.00) | 5.27 (4.30-6.46) | ||
R | 3.66 (3.11-4.31) | 3.68 (3.29-4.12) | 5.57 (2.67-11.62) | ||
Between levels | PB
| NS | NS | < 0.05 |
COPD | CB | ||||
---|---|---|---|---|---|
Characteristic | Level | Estimateb (SEc) | pd
| Estimateb (SEc) | pd
|
Constant | +1.011 (0.156) | +1.335 (0.258) | |||
Sex | Male | Base | < 0.05 | Base | NS |
Female | -0.218 (0.045) | -0.097 (0.043) | |||
Combined | -0.007 (0.045) | +0.039 (0.082) | |||
Continent | N America | Base | < 0.001 | Base | < 0.001 |
Europe | -0.347 (0.051) | -0.353 (0.052) | |||
Asia | -0.499 (0.079) | -0.493 (0.070) | |||
Other | -0.510 (0.081) | -0.144 (0.086) | |||
Disease definition | Mortality | Base | < 0.001 | Base | < 0.01 |
Lung function (COPD) or symptoms (CB) | -0.435 (0.071) | -0.104 (0.232) | |||
Other | +0.049 (0.076) | -0.406 (0.232) | |||
How asthma taken into account | Ignored | Base | < 0.001 | Base | < 0.05 |
Excluded | -0.334 (0.051) | +0.159 (0.076) | |||
Included in outcome definition | -0.721 (0.072) | No data | |||
Other | -0.055 (0.103) | +1.225 (0.237) | |||
Smoking product | Any | Base | < 0.05 | Base | NS |
Cigarettes (ignoring other products) | +0.255 (0.084) | -0.023 (0.136) | |||
Cigarettes only | +0.505 (0.099) | +0.410 (0.136) | |||
Unexposed group | Never any product | Base | < 0.01 | Base | NS |
Never cigarettes | -0.446 (0.077) | -0.127 (0.130) | |||
RR adjusted for age | Yes | Base | NS | Base | < 0.01 |
No | +0.076 (0.050) | +0.219 (0.039) | |||
RR adjusted for factor other than age or sex | Yes | Base | NS | Base | NS |
No | +0.148 (0.057) | -0.007 (0.072) | |||
Midpoint age | Per 10 years | +0.012 (0.002) | < 0.05 | +0.003 (0.002) | NS |
C. Risk from ever or current smoking
Preference | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|
Ever smoking to current smoking | n | 138 | 121 | 33 |
F | 2.47 (2.40-2.53) | 2.42 (2.36-2.48) | 3.32 (3.04-3.61) | |
R | 3.00 (2.71-3.32) | 2.70 (2.51-2.90) | 4.83 (3.46-6.73) | |
H, PH
| 10.61, < 0.001 | 5.61, < 0.001 | 9.95, < 0.001 | |
Current smoking to ever smoking | n | 139 | 121 | 33 |
F | 2.87 (2.79-2.95) | 2.82 (2.75-2.90) | 3.44 (3.13-3.78) | |
R | 3.46 (3.07-3.90) | 3.27 (3.02-3.54) | 5.05 (3.51-7.25) | |
H, PH
| 13.15, < 0.001 | 6.53, < 0.001 | 10.52, < 0.001 |
D. Risk from ex smoking
Factor | Level | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|---|
All | All | N | 110 | 105 | 17 |
F | 2.12 (2.05-2.19) | 1.56 (1.50-1.62) | 3.50 (3.13-3.92) | ||
R | 2.35 (2.11-2.63) | 1.63 (1.50-1.78) | 3.52 (2.51-4.94) | ||
H, PH
| 7.43, < 0.001 | 3.14, < 0.001 | 3.87, < 0.001 | ||
Sex | Male | n | 44 | 46 | 9 |
F | 2.80 (2.64-2.97) | 1.63 (1.52-1.76) | 5.12 (4.26-6.15) | ||
R | 2.87 (2.35-3.50) | 1.80 (1.57-2.06) | 4.70 (2.66-8.30) | ||
Female | n | 28 | 35 | 4 | |
F | 1.92 (1.78-2.06) | 1.52 (1.40-1.65) | 3.50 (2.36-5.19) | ||
R | 2.02 (1.53-1.68) | 1.64 (1.40-1.93) | 3.50 (2.36-5.19) | ||
Combined | n | 38 | 24 | 4 | |
F | 1.83 (1.74-1.92) | 1.54 (1.46-1.63) | 2.68 (2.30-3.12) | ||
R | 2.07 (1.83-2.35) | 1.44 (1.22-1.71) | 2.68 (1.58-4.54) | ||
Between levels | PB
| < 0.001 | NS | < 0.05 | |
Continent | N America | n | 36 | 37 | 9 |
F | 2.77 (2.61-2.93) | 1.45 (1.32-1.60) | 4.70 (3.97-5.57) | ||
R | 2.98 (2.35-3.78) | 1.47 (1.25-1.73) | 3.82 (2.30-6.34) | ||
Europe | n | 50 | 55 | 6 | |
F | 1.81 (1.73-1.89) | 1.57 (1.50-1.65) | 2.71 (2.32-3.17) | ||
R | 1.99 (1.76-2.25) | 1.71 (1.51-1.94) | 3.00 (1.70-5.28) | ||
Asia | n | 16 | 7 | 2 | |
F | 2.84 (2.91-3.25) | 1.94 (1.69-2.23) | 3.56 (1.88-6.75) | ||
R | 2.79 (2.23-3.48) | 2.17 (1.63-2.88) | 3.56 (1.88-6.75) | ||
Other or multicountry | n | 8 | 6 | 0 | |
F | 1.52 (1.31-1.76) | 1.34 (1.14-1.57) | |||
R | 1.58 (1.22-2.05) | 1.33 (1.13-1.57) | |||
Between levels | PB
| < 0.001 | NS | < 0.05 | |
Study type | Case-control | n | 11 | 9 | 0 |
F | 3.38 (2.78-4.10) | 1.65 (1.38-1.98) | |||
R | 3.45 (2.26-5.28) | 1.87 (1.18-2.96) | |||
Prospective | n | 35 | 10 | 4 | |
F | 3.92 (3.60-4.26) | 1.59 (1.40-1.81) | 5.32 (4.36-6.49) | ||
R | 2.88 (2.23-3.73) | 1.79 (1.24-2.60) | 2.99 (0.91-9.84) | ||
Cross-sectional | n | 64 | 86 | 13 | |
F | 1.85 (1.78-1.92) | 1.55 (1.49-1.62) | 2.87 (2.50-3.30) | ||
R | 1.99 (1.81-2.19) | 1.60 (1.45-1.75) | 3.16 (2.50-4.00) | ||
Between levels | PB
| < 0.001 | NS | < 0.01 | |
Outcome subtype | Mortality | n | 29 | 2 | 2 |
F | 4.41 (4.04-4.80) | 3.61 (2.61-4.99) | 6.02 (4.90-7.40) | ||
R | 3.55 (2.75-4.57) | 5.57 (1.56-19.92) | 6.56 (3.93-10.94) | ||
Lung function (COPD) or symptoms (CB) | n | 51 | 76 | - | |
F | 1.86 (1.78-1.93) | 1.39 (1.32-1.46) | |||
R | 1.92 (1.72-2.13) | 1.50 (1.36-1.64) | |||
Other | n | 30 | 27 | 15 | |
F | 1.87 (1.74-2.02) | 1.90 (1.78-2.04) | 2.78 (2.43-3.18) | ||
R | 2.18 (1.80-2.64) | 1.84 (1.58-2.14) | 2.95 (2.23-3.91) | ||
Between levels | PB
| < 0.001 | < 0.001 | < 0.001 | |
Smoking product | Any | n | 43 | 53 | 4 |
F | 1.76 (1.65-1.88) | 1.64 (1.55-1.74) | 2.72 (2.31-3.19) | ||
R | 2.09 (1.78-2.45) | 1.67 (1.45-1.93) | 2.72 (2.31-3.19) | ||
Cigarettes (ignoring other products) | n | 59 | 49 | 12 | |
F | 2.07 (1.99-2.15) | 1.46 (1.38-1.54) | 4.42 (3.76-5.18) | ||
R | 2.19 (1.94-2.47) | 1.53 (1.38-1.70) | 3.33 (2.17-5.10) | ||
Cigarettes only | n | 8 | 3 | 1 | |
F | 6.79 (5.87-7.86) | 2.80 (2.13-3.67) | 12.50 (3.53-44.27) | ||
R | 5.78 (3.81-8.77) | 3.28 (1.84-5.84) | 12.50 (3.53-44.27) | ||
Between levels | PB
| < 0.001 | < 0.05 | < 0.1 | |
Unexposed basec
| Never any product | n | 54 | 65 | 6 |
F | 2.41 (2.28-2.54) | 1.69 (1.60-1.79) | 3.67 (3.23-4.16) | ||
R | 2.60 (2.12-3.17) | 1.75 (1.53-2.01) | 4.70 (2.58-8.53) | ||
Never cigarettes | n | 56 | 40 | 11 | |
F | 1.96 (1.88-2.04) | 1.44 (1.36-1.52) | 2.93 (2.28-3.76) | ||
R | 2.15 (1.92-2.42) | 1.50 (1.35-1.66) | 2.99 (1.96-4.56) | ||
Between levels | PB
| < 0.05 | < 0.05 | NS |
E. Risk by amount smoked
Amount smoked | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|
Number of setsc
| 42 | 57 | 11 | |
About 5 cigs/dayd, g
| N | 40 | 53 | 9 |
F | 2.58 (2.39-2.78) | 2.04 (1.91-2.16) | 2.21 (1.88-2.59) | |
R | 2.89 (2.41-3.45) | 2.32 (2.07-2.60) | 4.24 (1.88-9.55) | |
H, PH
| 3.58, < 0.001 | 2.08, < 0.001 | 7.82, < 0.001 | |
About 20 cigs/daye, g
| N | 23 | 33 | 6 |
F | 6.24 (5.79-6.73) | 3.64 (3.33-3.98) | 7.10 (4.83-10.44) | |
R | 6.21 (4.72-8.17) | 4.43 (3.68-5.32) | 5.07 (2.04-12.61) | |
H, PH
| 7.83, < 0.001 | 3.32, < 0.001 | 3.56, < 0.01 | |
About 45 cigs/dayf, g
| N | 26 | 35 | 6 |
F | 9.83 (8.85-10.92) | 6.00 (5.48-6.57) | 12.39 (7.49-20.50) | |
R | 9.50 (7.38-12.22) | 7.37 (5.86-9.28) | 7.19 (2.74-18.87) | |
H, PH
| 3.28, < 0.001 | 4.66, < 0.001 | 2.23, < 0.05 | |
Highest v lowest | N | 44 | 62 | 11 |
F | 2.22 (2.08-2.37) | 1.99 (1.87-2.12) | 1.41 (1.17-1.70) | |
R | 2.32 (1.90-2.83) | 2.42 (2.10-2.79) | 2.73 (1.23-6.04) | |
H, PH
| 6.02, < 0.001 | 3.65, < 0.001 | 7.50, < 0.001 |
F. Risk by age of starting to smoke
Age started | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|
Number of setsc
| 10 | 2 | 2 | |
About age 26 yearsd, g
| N | 6 | Insufficient data | Insufficient data |
F | 1.74 (1.29-2.34) | |||
R | 1.91 (1.25-1.91) | |||
H, PH
| 1.48, NS | |||
About age 18 yearse, g
| N | 6 | Insufficient data | Insufficient data |
F | 1.96 (1.60-2.41) | |||
R | 2.11 (1.08-4.11) | |||
H, PH
| 7.43, < 0.001 | |||
About age 14 yearsf, g
| N | 8 | Insufficient data | Insufficient data |
F | 3.34 (2.74-2.08) | |||
R | 3.12 (2.07-4.70) | |||
H, PH
| 2.88, < 0.01 | |||
Earliest v latest | N | 14 | 6 | 2 |
F | 1.41 (1.30-1.52) | 1.99 (1.42-2.79) | 1.14 (0.70-1.88) | |
R | 1.49 (1.26-1.76) | 2.08 (1.29-3.35) | 1.14 (0.70-1.88) | |
H, PH
| 1.29, NS | 1.54, NS | 0.01, NS |
G. Risk by pack-years
Pack-years | Statisticb
| COPD | CB | Emphysema |
---|---|---|---|---|
Number of setsc
| 28 | 11 | 3 | |
About 5d, g
| N | 23 | 10 | Insufficient data |
F | 1.13 (1.06-1.20) | 2.11 (1.74-2.55) | ||
R | 1.25 (1.09-1.44) | 1.74 (1.17-2.58) | ||
H, PH
| 2.06, < 0.01 | 2.85, < 0.01 | ||
About 20e, g
| N | 11 | 8 | Insufficient data |
F | 1.68 (1.58-1.79) | 4.54 (3.69-5.58) | ||
R | 2.53 (1.87-3.43) | 4.54 (3.69-5.58) | ||
H, PH
| 4.44, < 0.001 | 0.63, NS | ||
About 45e, g
| N | 15 | 8 | Insufficient data |
F | 3.14 (2.97-3.32) | 7.33 (5.98-8.97) | ||
R | 3.69 (2.79-4.86) | 7.04 (5.06-9.79) | ||
H, PH
| 6.34, < 0.001 | 1.82, < 0.1 | ||
Highest v lowest | N | 31 | 11 | 3 |
F | 2.82 (2.69-2.97) | 2.52 (2.25-2.82) | 1.86 (1.40-2.47) | |
R | 2.80 (2.37-3.30) | 3.09 (2.33-4.10) | 2.42 (1.25-4.70) | |
H, PH
| 4.09, < 0.001 | 2.23, < 0.05 | 1.79, NS |
H. Risk by duration of smoking
Duration of smoking | Statisticc
| COPD | CB | Emphysema |
---|---|---|---|---|
Longest vs. shortest | N | 3 | 4 | 2 |
F | 1.12 (0.63-1.98) | 2.73 (1.52-4.92) | 7.82 (2.00-30.58) | |
R | 1.12 (0.63-1.98) | 2.25 (0.68-7.42) | 7.67 (0.15-390.65) | |
H, PH
| 0.76, NS | 3.60, < 0.05 | 8.31, < 0.01 |
I. Risk by duration of quitting (vs. never smoking)
Duration of quitting | Statisticb
| COPD | CB |
---|---|---|---|
Number of setsc
| 10 | 11 | |
About 12 yearsd, g
| n | 10 | 9 |
F | 3.45 (2.96-4.01) | 1.40 (1.21-2.62) | |
R | 2.12 (1.06-4.26) | 2.20 (1.33-3.65) | |
H, PH
| 12.74, < 0.001 | 8.04, < 0.001 | |
About 7 yearse, g
| n | 3 | 5 |
F | 8.15 (5.88-11.28) | 1.83 (1.49-2.25) | |
R | 4.94 (1.21-20.07) | 2.36 (1.29-4.32) | |
H, PH
| 14.80, < 0.001 | 6.52, < 0.001 | |
About 3 yearsf, g
| n | 3 | 7 |
F | 3.58 (2.44-5.25) | 2.16 (1.82-2.57) | |
R | 4.08 (0.80-20.77) | 2.42 (1.73-3.38) | |
H, PH
| 16.66, < 0.001 | 2.79, < 0.05 | |
Shortest v longest | n | 10 | 11 |
F | 2.20 (1.76-2.76) | 1.29 (1.06-1.56) | |
R | 2.21 (1.24-3.94) | 1.25 (0.99-1.59) | |
H, PH
| 4.88, < 0.001 | 1.29, NS |
J. Risk by duration of quitting (vs. current smoking)
Duration of quitting | Statisticb
| COPD | CB |
---|---|---|---|
Number of setsc
| 9 | 11 | |
About 3 yearsd, g
| n | 2 | 7 |
F | 0.77 (0.51-1.15) | 1.07 (0.91-1.25) | |
R | 0.77 (0.51-1.15) | 1.00 (0.70-1.43) | |
H, PH
| 0.28, NS | 3.85, < 0.001 | |
About 7 yearse, g
| n | 2 | 5 |
F | 1.03 (0.62-1.70) | 1.00 (0.84-1.19) | |
R | 1.03 (0.62-1.70) | 0.87 (0.47-1.61) | |
H, PH
| 0.53, NS | 9.89, < 0.001 | |
About 12 yearse, g
| n | 9 | 9 |
F | 0.52 (0.43-0.63) | 0.61 (0.53-0.69) | |
R | 0.52 (0.37-0.71) | 0.65 (0.41-1.04) | |
H, PH
| 1.93, < 0.1 | 9.11, < 0.001 | |
Longest v shortest | n | 10 | 11 |
F | 0.43 (0.34-0.53) | 0.78 (0.64-0.95) | |
R | 0.45 (0.24-0.84) | 0.80 (0.63-1.02) | |
H, PH
| 5.78, < 0.001 | 1.28, NS |
Further analyses based on within-study differences
Discussion
Evidence of a relationship
Heterogeneity
Sex
Age
Location
Study timing
Definition of the disease outcome
Study type
Aspects of smoking
Derivation of RRs
Effect of studies with high RRs or large weight
Studies included | Fixed-effects RR (95% CI) | Random-effects RR (95% CI) | Ha
|
---|---|---|---|
All 22 studies | 2.61 (2.33-2.93) | 4.87 (2.83-8.41) | 11.54 |
Exclude AUERBA | 2.36 (2.10-2.65) | 3.62 (2.50-5.24) | 4.48 |
Exclude LAVECC | 4.95 (4.10-5.97) | 5.20 (2.85-9.49) | 8.50 |
Exclude both | 3.89 (3.21-4.71) | 3.85 (2.71-5.47) | 2.55 |